The systemic nature of CKD
Key Points CKD is an inherently systemic disease Energy balance, innate immunity and neuroendocrine control of organ function are highly integrated biological processes; such integration is disrupted by loss of kidney function, which generates a high risk clinical phenotype The clinical profile of c...
Gespeichert in:
Veröffentlicht in: | Nature reviews. Nephrology 2017-06, Vol.13 (6), p.344-358 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 358 |
---|---|
container_issue | 6 |
container_start_page | 344 |
container_title | Nature reviews. Nephrology |
container_volume | 13 |
creator | Zoccali, Carmine Vanholder, Raymond Massy, Ziad A. Ortiz, Alberto Sarafidis, Pantelis Dekker, Friedo W. Fliser, Danilo Fouque, Denis Heine, Gunnar H. Jager, Kitty J. Kanbay, Mehmet Mallamaci, Francesca Parati, Gianfranco Rossignol, Patrick Wiecek, Andrzej London, Gerard |
description | Key Points
CKD is an inherently systemic disease
Energy balance, innate immunity and neuroendocrine control of organ function are highly integrated biological processes; such integration is disrupted by loss of kidney function, which generates a high risk clinical phenotype
The clinical profile of chronic kidney disease (CKD) includes inflammation, malnutrition, altered activity of the autonomic and central nervous systems, and cardiopulmonary, vascular and bone disease
The gut and the lung are emerging as critical mediators of the interaction between the kidney and the environment, and are involved in cardiovascular disease and other systemic complications of CKD
Alterations in macrovascular and microvascular function induced by sleep apnoea, inflammation and oxidative stress increase the risk of brain disease in CKD
The application of omics sciences will enable in-depth studies of the pathophysiology and treatment of CKD
Chronic kidney disease (CKD) affects numerous organs and systems, which in turn have effects on kidney function. This Review provides an overview of CKD as a systemic disease and discusses the multidirectional links between the kidney, bone, nervous and immune systems, and metabolism.
The accurate definition and staging of chronic kidney disease (CKD) is one of the major achievements of modern nephrology. Intensive research is now being undertaken to unravel the risk factors and pathophysiologic underpinnings of this disease. In particular, the relationships between the kidney and other organs have been comprehensively investigated in experimental and clinical studies in the last two decades. Owing to technological and analytical limitations, these links have been studied with a reductionist approach focusing on two organs at a time, such as the heart and the kidney or the bone and the kidney. Here, we discuss studies that highlight the complex and systemic nature of CKD. Energy balance, innate immunity and neuroendocrine signalling are highly integrated biological phenomena. The diseased kidney disrupts such integration and generates a high-risk phenotype with a clinical profile encompassing inflammation, protein–energy wasting, altered function of the autonomic and central nervous systems and cardiopulmonary, vascular and bone diseases. A systems biology approach to CKD using omics techniques will hopefully enable in-depth study of the pathophysiology of this systemic disease, and has the potential to unravel critical pathways that can |
doi_str_mv | 10.1038/nrneph.2017.52 |
format | Article |
fullrecord | <record><control><sourceid>gale_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01848408v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A491832070</galeid><sourcerecordid>A491832070</sourcerecordid><originalsourceid>FETCH-LOGICAL-c563t-e39d1a093599d39426775416ddf0e1cd9e93176d172a00d069734fa440c50bf43</originalsourceid><addsrcrecordid>eNp9ktFrFDEQxoMotlZfffBBDgqiD3ed2SSbzeNxals88KWCbyHdzHa37CVnsiv0vzfL1bOVo2QgYfL7vjCTYewtwgKBV2c-etq2iwJQLWTxjB2jknouQf18vj-XeMRepXQLUJZCyZfsqKgElyjVMXt31dIs3aWBNl0983YYI81CM1t9-_yavWhsn-jN_X7Cfnz9crW6mK-_n1-ulut5LUs-zIlrhxY0l1o7rkVRKiUFls41QFg7TZqjKh2qwgI4KLXiorFCQC3huhH8hH3a-ba2N9vYbWy8M8F25mK5NlMOsBKVgOo3Zvbjjt3G8GukNJhNl2rqe-spjMlgpVFIWUiV0dP_0NswRp8rMRwFz93jOZ6gspfmObj-R93YnkznmzBEW09Pm6XQWPECFGRqcYDKy03NDZ6aLucfCT48ELRk-6FNoR-HLvh00LmOIaVIzb5PCGaaA7ObAzPNgZFFFry_L2u83pDb438_PgNnOyDlK39D8UHdhy3_AJGztmk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1899399339</pqid></control><display><type>article</type><title>The systemic nature of CKD</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Zoccali, Carmine ; Vanholder, Raymond ; Massy, Ziad A. ; Ortiz, Alberto ; Sarafidis, Pantelis ; Dekker, Friedo W. ; Fliser, Danilo ; Fouque, Denis ; Heine, Gunnar H. ; Jager, Kitty J. ; Kanbay, Mehmet ; Mallamaci, Francesca ; Parati, Gianfranco ; Rossignol, Patrick ; Wiecek, Andrzej ; London, Gerard</creator><creatorcontrib>Zoccali, Carmine ; Vanholder, Raymond ; Massy, Ziad A. ; Ortiz, Alberto ; Sarafidis, Pantelis ; Dekker, Friedo W. ; Fliser, Danilo ; Fouque, Denis ; Heine, Gunnar H. ; Jager, Kitty J. ; Kanbay, Mehmet ; Mallamaci, Francesca ; Parati, Gianfranco ; Rossignol, Patrick ; Wiecek, Andrzej ; London, Gerard ; European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA) ; on behalf of the European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA)</creatorcontrib><description>Key Points
CKD is an inherently systemic disease
Energy balance, innate immunity and neuroendocrine control of organ function are highly integrated biological processes; such integration is disrupted by loss of kidney function, which generates a high risk clinical phenotype
The clinical profile of chronic kidney disease (CKD) includes inflammation, malnutrition, altered activity of the autonomic and central nervous systems, and cardiopulmonary, vascular and bone disease
The gut and the lung are emerging as critical mediators of the interaction between the kidney and the environment, and are involved in cardiovascular disease and other systemic complications of CKD
Alterations in macrovascular and microvascular function induced by sleep apnoea, inflammation and oxidative stress increase the risk of brain disease in CKD
The application of omics sciences will enable in-depth studies of the pathophysiology and treatment of CKD
Chronic kidney disease (CKD) affects numerous organs and systems, which in turn have effects on kidney function. This Review provides an overview of CKD as a systemic disease and discusses the multidirectional links between the kidney, bone, nervous and immune systems, and metabolism.
The accurate definition and staging of chronic kidney disease (CKD) is one of the major achievements of modern nephrology. Intensive research is now being undertaken to unravel the risk factors and pathophysiologic underpinnings of this disease. In particular, the relationships between the kidney and other organs have been comprehensively investigated in experimental and clinical studies in the last two decades. Owing to technological and analytical limitations, these links have been studied with a reductionist approach focusing on two organs at a time, such as the heart and the kidney or the bone and the kidney. Here, we discuss studies that highlight the complex and systemic nature of CKD. Energy balance, innate immunity and neuroendocrine signalling are highly integrated biological phenomena. The diseased kidney disrupts such integration and generates a high-risk phenotype with a clinical profile encompassing inflammation, protein–energy wasting, altered function of the autonomic and central nervous systems and cardiopulmonary, vascular and bone diseases. A systems biology approach to CKD using omics techniques will hopefully enable in-depth study of the pathophysiology of this systemic disease, and has the potential to unravel critical pathways that can be targeted for CKD prevention and therapy.</description><identifier>ISSN: 1759-5061</identifier><identifier>ISSN: 1759-507X</identifier><identifier>EISSN: 1759-507X</identifier><identifier>DOI: 10.1038/nrneph.2017.52</identifier><identifier>PMID: 28435157</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/4022/1585/104 ; 692/698/1543/1565 ; 692/699/1670/316 ; 692/699/75 ; Amino acids ; Animals ; Biomarkers ; Bone Diseases - etiology ; Care and treatment ; Chronic kidney failure ; Development and progression ; Diagnosis ; Energy ; Energy Metabolism ; Energy storage ; Epidemiology ; Glucose ; Heart Diseases - etiology ; Hemodialysis ; Homeostasis ; Hormones ; Hospitals ; Humans ; Hypertension ; Immune system ; Immunity ; Immunity (Disease) ; Inflammation ; Inflammation - etiology ; Insulin resistance ; Internal medicine ; Kidney diseases ; Life Sciences ; Lung Diseases - etiology ; Medicine ; Medicine & Public Health ; Metabolic Diseases - etiology ; Metabolism ; Nephrology ; Nervous System Diseases - etiology ; Pathophysiology ; Renal Insufficiency, Chronic - complications ; Renal Insufficiency, Chronic - immunology ; Renal Insufficiency, Chronic - metabolism ; review-article ; Systemic diseases ; Transplants & implants</subject><ispartof>Nature reviews. Nephrology, 2017-06, Vol.13 (6), p.344-358</ispartof><rights>Springer Nature Limited 2017</rights><rights>COPYRIGHT 2017 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Jun 2017</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c563t-e39d1a093599d39426775416ddf0e1cd9e93176d172a00d069734fa440c50bf43</citedby><cites>FETCH-LOGICAL-c563t-e39d1a093599d39426775416ddf0e1cd9e93176d172a00d069734fa440c50bf43</cites><orcidid>0000-0002-9707-7199 ; 0000-0002-7212-2061</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/nrneph.2017.52$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/nrneph.2017.52$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28435157$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-01848408$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Zoccali, Carmine</creatorcontrib><creatorcontrib>Vanholder, Raymond</creatorcontrib><creatorcontrib>Massy, Ziad A.</creatorcontrib><creatorcontrib>Ortiz, Alberto</creatorcontrib><creatorcontrib>Sarafidis, Pantelis</creatorcontrib><creatorcontrib>Dekker, Friedo W.</creatorcontrib><creatorcontrib>Fliser, Danilo</creatorcontrib><creatorcontrib>Fouque, Denis</creatorcontrib><creatorcontrib>Heine, Gunnar H.</creatorcontrib><creatorcontrib>Jager, Kitty J.</creatorcontrib><creatorcontrib>Kanbay, Mehmet</creatorcontrib><creatorcontrib>Mallamaci, Francesca</creatorcontrib><creatorcontrib>Parati, Gianfranco</creatorcontrib><creatorcontrib>Rossignol, Patrick</creatorcontrib><creatorcontrib>Wiecek, Andrzej</creatorcontrib><creatorcontrib>London, Gerard</creatorcontrib><creatorcontrib>European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA)</creatorcontrib><creatorcontrib>on behalf of the European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA)</creatorcontrib><title>The systemic nature of CKD</title><title>Nature reviews. Nephrology</title><addtitle>Nat Rev Nephrol</addtitle><addtitle>Nat Rev Nephrol</addtitle><description>Key Points
CKD is an inherently systemic disease
Energy balance, innate immunity and neuroendocrine control of organ function are highly integrated biological processes; such integration is disrupted by loss of kidney function, which generates a high risk clinical phenotype
The clinical profile of chronic kidney disease (CKD) includes inflammation, malnutrition, altered activity of the autonomic and central nervous systems, and cardiopulmonary, vascular and bone disease
The gut and the lung are emerging as critical mediators of the interaction between the kidney and the environment, and are involved in cardiovascular disease and other systemic complications of CKD
Alterations in macrovascular and microvascular function induced by sleep apnoea, inflammation and oxidative stress increase the risk of brain disease in CKD
The application of omics sciences will enable in-depth studies of the pathophysiology and treatment of CKD
Chronic kidney disease (CKD) affects numerous organs and systems, which in turn have effects on kidney function. This Review provides an overview of CKD as a systemic disease and discusses the multidirectional links between the kidney, bone, nervous and immune systems, and metabolism.
The accurate definition and staging of chronic kidney disease (CKD) is one of the major achievements of modern nephrology. Intensive research is now being undertaken to unravel the risk factors and pathophysiologic underpinnings of this disease. In particular, the relationships between the kidney and other organs have been comprehensively investigated in experimental and clinical studies in the last two decades. Owing to technological and analytical limitations, these links have been studied with a reductionist approach focusing on two organs at a time, such as the heart and the kidney or the bone and the kidney. Here, we discuss studies that highlight the complex and systemic nature of CKD. Energy balance, innate immunity and neuroendocrine signalling are highly integrated biological phenomena. The diseased kidney disrupts such integration and generates a high-risk phenotype with a clinical profile encompassing inflammation, protein–energy wasting, altered function of the autonomic and central nervous systems and cardiopulmonary, vascular and bone diseases. A systems biology approach to CKD using omics techniques will hopefully enable in-depth study of the pathophysiology of this systemic disease, and has the potential to unravel critical pathways that can be targeted for CKD prevention and therapy.</description><subject>692/4022/1585/104</subject><subject>692/698/1543/1565</subject><subject>692/699/1670/316</subject><subject>692/699/75</subject><subject>Amino acids</subject><subject>Animals</subject><subject>Biomarkers</subject><subject>Bone Diseases - etiology</subject><subject>Care and treatment</subject><subject>Chronic kidney failure</subject><subject>Development and progression</subject><subject>Diagnosis</subject><subject>Energy</subject><subject>Energy Metabolism</subject><subject>Energy storage</subject><subject>Epidemiology</subject><subject>Glucose</subject><subject>Heart Diseases - etiology</subject><subject>Hemodialysis</subject><subject>Homeostasis</subject><subject>Hormones</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Immune system</subject><subject>Immunity</subject><subject>Immunity (Disease)</subject><subject>Inflammation</subject><subject>Inflammation - etiology</subject><subject>Insulin resistance</subject><subject>Internal medicine</subject><subject>Kidney diseases</subject><subject>Life Sciences</subject><subject>Lung Diseases - etiology</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metabolic Diseases - etiology</subject><subject>Metabolism</subject><subject>Nephrology</subject><subject>Nervous System Diseases - etiology</subject><subject>Pathophysiology</subject><subject>Renal Insufficiency, Chronic - complications</subject><subject>Renal Insufficiency, Chronic - immunology</subject><subject>Renal Insufficiency, Chronic - metabolism</subject><subject>review-article</subject><subject>Systemic diseases</subject><subject>Transplants & implants</subject><issn>1759-5061</issn><issn>1759-507X</issn><issn>1759-507X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9ktFrFDEQxoMotlZfffBBDgqiD3ed2SSbzeNxals88KWCbyHdzHa37CVnsiv0vzfL1bOVo2QgYfL7vjCTYewtwgKBV2c-etq2iwJQLWTxjB2jknouQf18vj-XeMRepXQLUJZCyZfsqKgElyjVMXt31dIs3aWBNl0983YYI81CM1t9-_yavWhsn-jN_X7Cfnz9crW6mK-_n1-ulut5LUs-zIlrhxY0l1o7rkVRKiUFls41QFg7TZqjKh2qwgI4KLXiorFCQC3huhH8hH3a-ba2N9vYbWy8M8F25mK5NlMOsBKVgOo3Zvbjjt3G8GukNJhNl2rqe-spjMlgpVFIWUiV0dP_0NswRp8rMRwFz93jOZ6gspfmObj-R93YnkznmzBEW09Pm6XQWPECFGRqcYDKy03NDZ6aLucfCT48ELRk-6FNoR-HLvh00LmOIaVIzb5PCGaaA7ObAzPNgZFFFry_L2u83pDb438_PgNnOyDlK39D8UHdhy3_AJGztmk</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Zoccali, Carmine</creator><creator>Vanholder, Raymond</creator><creator>Massy, Ziad A.</creator><creator>Ortiz, Alberto</creator><creator>Sarafidis, Pantelis</creator><creator>Dekker, Friedo W.</creator><creator>Fliser, Danilo</creator><creator>Fouque, Denis</creator><creator>Heine, Gunnar H.</creator><creator>Jager, Kitty J.</creator><creator>Kanbay, Mehmet</creator><creator>Mallamaci, Francesca</creator><creator>Parati, Gianfranco</creator><creator>Rossignol, Patrick</creator><creator>Wiecek, Andrzej</creator><creator>London, Gerard</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-9707-7199</orcidid><orcidid>https://orcid.org/0000-0002-7212-2061</orcidid></search><sort><creationdate>20170601</creationdate><title>The systemic nature of CKD</title><author>Zoccali, Carmine ; Vanholder, Raymond ; Massy, Ziad A. ; Ortiz, Alberto ; Sarafidis, Pantelis ; Dekker, Friedo W. ; Fliser, Danilo ; Fouque, Denis ; Heine, Gunnar H. ; Jager, Kitty J. ; Kanbay, Mehmet ; Mallamaci, Francesca ; Parati, Gianfranco ; Rossignol, Patrick ; Wiecek, Andrzej ; London, Gerard</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c563t-e39d1a093599d39426775416ddf0e1cd9e93176d172a00d069734fa440c50bf43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>692/4022/1585/104</topic><topic>692/698/1543/1565</topic><topic>692/699/1670/316</topic><topic>692/699/75</topic><topic>Amino acids</topic><topic>Animals</topic><topic>Biomarkers</topic><topic>Bone Diseases - etiology</topic><topic>Care and treatment</topic><topic>Chronic kidney failure</topic><topic>Development and progression</topic><topic>Diagnosis</topic><topic>Energy</topic><topic>Energy Metabolism</topic><topic>Energy storage</topic><topic>Epidemiology</topic><topic>Glucose</topic><topic>Heart Diseases - etiology</topic><topic>Hemodialysis</topic><topic>Homeostasis</topic><topic>Hormones</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Immune system</topic><topic>Immunity</topic><topic>Immunity (Disease)</topic><topic>Inflammation</topic><topic>Inflammation - etiology</topic><topic>Insulin resistance</topic><topic>Internal medicine</topic><topic>Kidney diseases</topic><topic>Life Sciences</topic><topic>Lung Diseases - etiology</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metabolic Diseases - etiology</topic><topic>Metabolism</topic><topic>Nephrology</topic><topic>Nervous System Diseases - etiology</topic><topic>Pathophysiology</topic><topic>Renal Insufficiency, Chronic - complications</topic><topic>Renal Insufficiency, Chronic - immunology</topic><topic>Renal Insufficiency, Chronic - metabolism</topic><topic>review-article</topic><topic>Systemic diseases</topic><topic>Transplants & implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zoccali, Carmine</creatorcontrib><creatorcontrib>Vanholder, Raymond</creatorcontrib><creatorcontrib>Massy, Ziad A.</creatorcontrib><creatorcontrib>Ortiz, Alberto</creatorcontrib><creatorcontrib>Sarafidis, Pantelis</creatorcontrib><creatorcontrib>Dekker, Friedo W.</creatorcontrib><creatorcontrib>Fliser, Danilo</creatorcontrib><creatorcontrib>Fouque, Denis</creatorcontrib><creatorcontrib>Heine, Gunnar H.</creatorcontrib><creatorcontrib>Jager, Kitty J.</creatorcontrib><creatorcontrib>Kanbay, Mehmet</creatorcontrib><creatorcontrib>Mallamaci, Francesca</creatorcontrib><creatorcontrib>Parati, Gianfranco</creatorcontrib><creatorcontrib>Rossignol, Patrick</creatorcontrib><creatorcontrib>Wiecek, Andrzej</creatorcontrib><creatorcontrib>London, Gerard</creatorcontrib><creatorcontrib>European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA)</creatorcontrib><creatorcontrib>on behalf of the European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Nature reviews. Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zoccali, Carmine</au><au>Vanholder, Raymond</au><au>Massy, Ziad A.</au><au>Ortiz, Alberto</au><au>Sarafidis, Pantelis</au><au>Dekker, Friedo W.</au><au>Fliser, Danilo</au><au>Fouque, Denis</au><au>Heine, Gunnar H.</au><au>Jager, Kitty J.</au><au>Kanbay, Mehmet</au><au>Mallamaci, Francesca</au><au>Parati, Gianfranco</au><au>Rossignol, Patrick</au><au>Wiecek, Andrzej</au><au>London, Gerard</au><aucorp>European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA)</aucorp><aucorp>on behalf of the European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The systemic nature of CKD</atitle><jtitle>Nature reviews. Nephrology</jtitle><stitle>Nat Rev Nephrol</stitle><addtitle>Nat Rev Nephrol</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>13</volume><issue>6</issue><spage>344</spage><epage>358</epage><pages>344-358</pages><issn>1759-5061</issn><issn>1759-507X</issn><eissn>1759-507X</eissn><abstract>Key Points
CKD is an inherently systemic disease
Energy balance, innate immunity and neuroendocrine control of organ function are highly integrated biological processes; such integration is disrupted by loss of kidney function, which generates a high risk clinical phenotype
The clinical profile of chronic kidney disease (CKD) includes inflammation, malnutrition, altered activity of the autonomic and central nervous systems, and cardiopulmonary, vascular and bone disease
The gut and the lung are emerging as critical mediators of the interaction between the kidney and the environment, and are involved in cardiovascular disease and other systemic complications of CKD
Alterations in macrovascular and microvascular function induced by sleep apnoea, inflammation and oxidative stress increase the risk of brain disease in CKD
The application of omics sciences will enable in-depth studies of the pathophysiology and treatment of CKD
Chronic kidney disease (CKD) affects numerous organs and systems, which in turn have effects on kidney function. This Review provides an overview of CKD as a systemic disease and discusses the multidirectional links between the kidney, bone, nervous and immune systems, and metabolism.
The accurate definition and staging of chronic kidney disease (CKD) is one of the major achievements of modern nephrology. Intensive research is now being undertaken to unravel the risk factors and pathophysiologic underpinnings of this disease. In particular, the relationships between the kidney and other organs have been comprehensively investigated in experimental and clinical studies in the last two decades. Owing to technological and analytical limitations, these links have been studied with a reductionist approach focusing on two organs at a time, such as the heart and the kidney or the bone and the kidney. Here, we discuss studies that highlight the complex and systemic nature of CKD. Energy balance, innate immunity and neuroendocrine signalling are highly integrated biological phenomena. The diseased kidney disrupts such integration and generates a high-risk phenotype with a clinical profile encompassing inflammation, protein–energy wasting, altered function of the autonomic and central nervous systems and cardiopulmonary, vascular and bone diseases. A systems biology approach to CKD using omics techniques will hopefully enable in-depth study of the pathophysiology of this systemic disease, and has the potential to unravel critical pathways that can be targeted for CKD prevention and therapy.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>28435157</pmid><doi>10.1038/nrneph.2017.52</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-9707-7199</orcidid><orcidid>https://orcid.org/0000-0002-7212-2061</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1759-5061 |
ispartof | Nature reviews. Nephrology, 2017-06, Vol.13 (6), p.344-358 |
issn | 1759-5061 1759-507X 1759-507X |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_01848408v1 |
source | MEDLINE; Springer Nature - Complete Springer Journals |
subjects | 692/4022/1585/104 692/698/1543/1565 692/699/1670/316 692/699/75 Amino acids Animals Biomarkers Bone Diseases - etiology Care and treatment Chronic kidney failure Development and progression Diagnosis Energy Energy Metabolism Energy storage Epidemiology Glucose Heart Diseases - etiology Hemodialysis Homeostasis Hormones Hospitals Humans Hypertension Immune system Immunity Immunity (Disease) Inflammation Inflammation - etiology Insulin resistance Internal medicine Kidney diseases Life Sciences Lung Diseases - etiology Medicine Medicine & Public Health Metabolic Diseases - etiology Metabolism Nephrology Nervous System Diseases - etiology Pathophysiology Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - immunology Renal Insufficiency, Chronic - metabolism review-article Systemic diseases Transplants & implants |
title | The systemic nature of CKD |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T13%3A55%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20systemic%20nature%20of%20CKD&rft.jtitle=Nature%20reviews.%20Nephrology&rft.au=Zoccali,%20Carmine&rft.aucorp=European%20Renal%20and%20Cardiovascular%20Medicine%20(EURECA-m)%20Working%20Group%20of%20the%20European%20Renal%20Association%20%E2%80%93%20European%20Dialysis%20Transplantation%20Association%20(ERA-EDTA)&rft.date=2017-06-01&rft.volume=13&rft.issue=6&rft.spage=344&rft.epage=358&rft.pages=344-358&rft.issn=1759-5061&rft.eissn=1759-507X&rft_id=info:doi/10.1038/nrneph.2017.52&rft_dat=%3Cgale_hal_p%3EA491832070%3C/gale_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1899399339&rft_id=info:pmid/28435157&rft_galeid=A491832070&rfr_iscdi=true |